Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case

Dear Editor, Rhabdomyosarcoma (RMS) is a rare, aggressive, and malignant neoplasm with rapid growth composed of primitive mesenchymal cells that exhibit skeletal muscle differentiation and mainly affects children and adolescents (60%) [1]. RMS is the most common soft tissue sarcoma with a rate of 50...

Full description

Saved in:
Bibliographic Details
Main Authors: Betül Şimşek, Esin Doğan, Didar Gürsoy Kuzuluk, Mustafa Cemaloğlu
Format: Article
Language:English
Published: Istanbul University Press 2023-12-01
Series:Çocuk Dergisi
Subjects:
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/EE2468EA9A9B4B10B5A71333D49BD390
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850274002355879936
author Betül Şimşek
Esin Doğan
Didar Gürsoy Kuzuluk
Mustafa Cemaloğlu
author_facet Betül Şimşek
Esin Doğan
Didar Gürsoy Kuzuluk
Mustafa Cemaloğlu
author_sort Betül Şimşek
collection DOAJ
description Dear Editor, Rhabdomyosarcoma (RMS) is a rare, aggressive, and malignant neoplasm with rapid growth composed of primitive mesenchymal cells that exhibit skeletal muscle differentiation and mainly affects children and adolescents (60%) [1]. RMS is the most common soft tissue sarcoma with a rate of 50-60% in pediatric patients and ranks third among pediatric extracranial solid tumors, following Wilms tumor and neuroblastoma at a rate of 4-5% [2]. Head and neck localizations constitute 35–40% of cases, with oral lesions being extremely rare [3]. RMS has four well-defined subtypes: embryonal, alveolar, spindle cell/sclerosing, and pleomorphic. Embryonal RMS comprises 70-75% of all RMS cases [4], which are mostly sporadic. However, an increase has occurred in the number of recent studies on RMS, and the conclusions of these studies have shown that the children detected with defects in the RAS or Hedgehog pathways, as well as those with predisposing familial syndromes, carry a higher risk for developing embryonal RMS. In addition, PAX3-FOX01 and PAX7-FOXO1 fusions have been identified in alveolar RMS and been accepted as diagnostic markers by many researchers [4-7]. The literature describes the clinical signs and symptoms of oral RMS as rapidly growing swelling, facial asymmetry, paresthesia, trismus, and difficulty swallowing [1,8].
format Article
id doaj-art-e952c09f5c41474ebccceba3fc507c33
institution OA Journals
issn 1308-8491
language English
publishDate 2023-12-01
publisher Istanbul University Press
record_format Article
series Çocuk Dergisi
spelling doaj-art-e952c09f5c41474ebccceba3fc507c332025-08-20T01:51:16ZengIstanbul University PressÇocuk Dergisi1308-84912023-12-0123439940010.26650/jchild.2023.1324273123456Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare CaseBetül Şimşek0https://orcid.org/0000-0002-7115-5259Esin Doğan1https://orcid.org/0000-0003-3785-6032Didar Gürsoy Kuzuluk2https://orcid.org/0000-0002-0674-7047Mustafa Cemaloğlu3https://orcid.org/0000-0001-7263-6962Hatay Mustafa Kemal Üniversitesi, Hatay, TurkiyeHatay Mustafa Kemal Üniversitesi, Hatay, TurkiyeHatay Mustafa Kemal Üniversitesi, Hatay, TurkiyeHatay Eğitim ve Araştırma Hastanesi, Hatay, TürkiyeDear Editor, Rhabdomyosarcoma (RMS) is a rare, aggressive, and malignant neoplasm with rapid growth composed of primitive mesenchymal cells that exhibit skeletal muscle differentiation and mainly affects children and adolescents (60%) [1]. RMS is the most common soft tissue sarcoma with a rate of 50-60% in pediatric patients and ranks third among pediatric extracranial solid tumors, following Wilms tumor and neuroblastoma at a rate of 4-5% [2]. Head and neck localizations constitute 35–40% of cases, with oral lesions being extremely rare [3]. RMS has four well-defined subtypes: embryonal, alveolar, spindle cell/sclerosing, and pleomorphic. Embryonal RMS comprises 70-75% of all RMS cases [4], which are mostly sporadic. However, an increase has occurred in the number of recent studies on RMS, and the conclusions of these studies have shown that the children detected with defects in the RAS or Hedgehog pathways, as well as those with predisposing familial syndromes, carry a higher risk for developing embryonal RMS. In addition, PAX3-FOX01 and PAX7-FOXO1 fusions have been identified in alveolar RMS and been accepted as diagnostic markers by many researchers [4-7]. The literature describes the clinical signs and symptoms of oral RMS as rapidly growing swelling, facial asymmetry, paresthesia, trismus, and difficulty swallowing [1,8].https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/EE2468EA9A9B4B10B5A71333D49BD390rhabdomyosarcomapathologyoncologypediatrics
spellingShingle Betül Şimşek
Esin Doğan
Didar Gürsoy Kuzuluk
Mustafa Cemaloğlu
Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case
Çocuk Dergisi
rhabdomyosarcoma
pathology
oncology
pediatrics
title Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case
title_full Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case
title_fullStr Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case
title_full_unstemmed Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case
title_short Rhabdomyosarcoma in the Oral Cavity of A Pediatric Patient: A Rare Case
title_sort rhabdomyosarcoma in the oral cavity of a pediatric patient a rare case
topic rhabdomyosarcoma
pathology
oncology
pediatrics
url https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/EE2468EA9A9B4B10B5A71333D49BD390
work_keys_str_mv AT betulsimsek rhabdomyosarcomaintheoralcavityofapediatricpatientararecase
AT esindogan rhabdomyosarcomaintheoralcavityofapediatricpatientararecase
AT didargursoykuzuluk rhabdomyosarcomaintheoralcavityofapediatricpatientararecase
AT mustafacemaloglu rhabdomyosarcomaintheoralcavityofapediatricpatientararecase